0
maybe. maybe not. Playing with the gods creations is not v safe
Wiki User
∙ 12y ago
Add your answer:
Earn +20 pts
Are there carriers for albinism?
Yes. If either parent is a carrier of the gene that causes albinism then their child becomes a carrier as well. It is only when both parents have the gene for albinism that the child is born with this disorder.
Is albinism heterozygous or homozygous?
genetically albinism is an autosomal recessive gene which in fact gives the child a 25% chance of inheriting the gene if both parents are carriers
Inserting working copies of a gene directly into the cells of a person with a genetic disorder is called what?
Gene TherapyGenetic disorders are caused by an abnormality in person's DNA.
Is it possible to find out if you are carrier of albinism?
Albinism is a recessively inherited disease. People with albinism has inherited 2 albinism genes. They got one gene from each parent.
Why do you need gene therapy?
gene therapy is when a faulty gene is repaired or replaced
Why does gene therapy not always work?
it depends on the gene some are so malfunctioned they cant be treated i cant believe none of you could answer this way to go doctors
Difference between gene therapy and protein therapy?
at the gene level gene therapy is done and at the the protein level protein therapy is done
What results from a recessive gene that prevents the making of pigments?
albinism
Albinism is a recessive trait in humans that is controlled by a single gene how many recessive alleles must a person have to have albinism?
2
How can albinism ba treated?
yo mammas mamma
Is albinism a recessive trait or dominant?
Recessive. The trait will only show up if both parents have the gene recessively (aa). If the genetic make up is Aa or AA, there will be melanin production, meaning albinism is an aa gene only. Albinism is a recessive allele.
What conditions can not be treated by gene therapy?
Many of the more commonly occurring disorders, including heart disease, diabetes, and high blood pressure, result from defects in multiple genes making them unlikely candidates for gene therapy using existing technologies.
